Decera Clinical Education Infectious Disease Podcast

Listen in as Dr Trevor Van Schooneveld explores rapid syndromic testing for gastrointestinal and joint infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing.  Topics covered include:  Who should be tested for infectious diarrhea Types of gastrointestinal syndromic panels Types of syndromic panels for joint infections Real-world appli...

Listen in as Dr Marcus Pereira discusses how to design cytomegalovirus (CMV) antiviral regimens for high-risk kidney transplant recipients to mitigate the impact of infection while minimizing drug toxicities. Topics include:  Strategies for CMV prevention: prophylaxis, preemptive therapy, and hybrid methods Characteristics of available antiviral drugs Monitoring considerations for antivirals Prese...

Join Alicia Stillman of the American Society for Meningitis Prevention, as she shares a very personal story of loss that might change how you view meningitis vaccination. Presenter: Alicia Stillman, MBA, MPH Patient Advocate Co-Executive Director, American Society for Meningitis Prevention Executive Director, Emily Stillman Foundation Detroit, Michigan Link to full program: https://bit.ly/4mYvTXQ...

Listen in as Michael Satlin, MD, MS, FIDSA,explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing. Topics covered include: Types of upper and lower respiratory infection panels Considerations for when to use respiratory syndromic testing How to use syndromic testing to guide both therap...

Stream this podcast to learn from experts Alexis E. Horace, PharmD, BCACP , andNimish Patel, PharmD, PhD, AAHIVP, how specialist pharmacists can overcome key barriers to care and apply best practices for optimization of antiretroviral therapy for HIV. Topics covered include:  Leveraging pharmacists’ expertise to advance HIV treatment Pharmacist roles in HIV care and management  The current ART lan...

Tune in to learn how the recent FDA approval of lenacapavir (LEN) for PreP integrates into the current field of HIV prevention. Listen on the go or follow along with our expert-curated slides . Topics covered include:  The current landscape of PrEP FDA approval of lenacapavir Phase III efficacy and safety data for lenacapavir Recommendations and perspectives on the future of PrEP Presenters: Colle...

Hear from experts in HIV care Beatriz Grinsztejn, MD, PhD, and Rosie Mnggibisa, MBChB, MPH, as they discuss their insights on some of the most clinically relevant new data presented at IAS 2025, including studies on:  Gaps in care for adolescents and young adults living with HIV Global impact of funding cuts Antiretroviral therapy for treating HIV Patient management strategies for people living wi...

Listen in as Dr Emily Heil explores rapid syndromic testing for bloodstream infections and discusses how to apply best practices for diagnostic and antimicrobial stewardship in syndromic testing. Topics covered include: The importance of good blood culture practices and finding the balance between overuse and underuse Blood culture improvement programs The utility of rapid diagnostic tests Resista...

Tune in as Dr George Behrenspresents the fundamentals on specialized agents for treatment-experienced people living with HIV. Topics covered include: Key targets and mechanisms of action for specialized HIV drugs Clinical trial data supporting safety and efficacy of these agents Considerations for potential drug–drug interactions  Strategies for leveraging these agents to construct new ART regimen...

In this episode, Dr Josep M. Llibrereviews the essentials on ART selection for treatment-experienced people with HIV and comorbidities.  Topics covered include: Underlying reasons for development of multidrug-resistant HIV Inflammation and immune activation associated with frequency of age-related conditions  General principles for designing ART regimens for persons with multidrug-resistant HIV Tr...

Tune in as Dr Daniel R. Kuritzkes presents a quick and easy primer on managing multidrug resistant HIV.  Topics covered include: How to recognize key populations who may present with multidrug-resistant HIV Identifying underlying reasons for regimen failure Evaluating resistance profiles Constructing new ART regimens for treatment-experienced individuals. Presenters: Daniel R. Kuritzkes, MD Chief,...

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include: Steatotic liver disease and PBC Vibration-controlled transient elastography (VCTE) and discordant biochemical respons...

Listen as expert faculty answer your most pressing questions on optimizing immunization in clinical practice. Topics covered include: Practical methods for improving confidence in vaccines How to educate patients on vaccine development and safety monitoring  Effective strategies to tailor recommendations, such as motivational interviewing Ways to navigate clinical encounters and address vaccine he...

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including: Disease concerns and frequently asked questions from a patient perspective Managing symptoms Treatment options and...

In this podcast, Sonal Kumar, MD, MPH, meets with patient advocate Maria Morais to discuss actionable steps that healthcare providers can incorporate into the care of people with primary biliary cholangitis (PBC). Listen as they discuss: The chronic nature of PBC Going beyond biochemical markers to assess and address symptoms such as fatigue and pruritus The importance of referral to patient suppo...

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau, use an illustrative patient case to explore the roles of ALP and other biochemical markers in PBC management, and explain what to expect from treatment. Topics covered include:  How baseline ALP can affect ALP normalization after second-line treatment with elafibranor and seladelpar Potential outcomes if ALP normalization cannot...

In this podcast, expert faculty, Dr Stuart Gordon and Dr Nancy Reau discuss an illustrative patient case to demonstrate how they individualize primary biliary cholangitis (PBC) therapy for patients ​with cirrhosis. Topics covered include: AASLD guideline recommendations for second-line therapy for PBC Considerations when using newer agents for second-line treatment of PBC in patients with cirrhosi...

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including: The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection) Cough as the most significant symptom and burden Imaging bronchiectasis with classic and...

In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss how they assess the symptoms of primary biliary cholangitis (PBC) and explore how new therapeutic agents may help alleviate symptom burden. Topics include: Strategies and tools for assessing pruritus Nonpharmacologic and pharmacologic management of pruritus Second-line agents and their impact on pruritus Investi...

How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including: How and when to measure treatment response Evidence-based goals of therapy Considerations for second-line treatment New agents for second-line treatment: PPAR agonists...

Respiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions. In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients...

Listen in as Carolyn Bridges, MD, FACP, and Laura P. Hurley, MD, MPH, discuss barriers to respiratory syncytial virus (RSV) vaccination for adults, including insurance coverage and vaccine hesitancy, and explore effective, practical strategies for overcoming these barriers. Topics covered include: Helping patients understand why they need an RSV vaccine Ways to discuss real-world vaccine efficacy...

Listen in as Carolyn Bridges, MD, FACP, reviews the estimated burden of respiratory syncytial virus (RSV) disease in older adults and discusses the latest updates on RSV vaccination recommendations and safety data. Topics covered include:  Rates of RSV hospitalizations and emergency department visits RSV vaccine development FDA-approved RSV vaccines Vaccine safety data: rates of atrial fibrillatio...

In this episode, Jewel Mullen, MD, MPH, MPA, and Dallas Nelson, MD, CMD, FACP discuss overcoming barriers to RSV vaccine uptake in post-acute and long-term care facilities, including: How to incorporate the latest RSV vaccination recommendations into clinical practice Practical strategies for navigating insurance Effective and empathetic methods of addressing vaccine hesitancy.    Presenters: Jewe...

In this episode, Chloe Orkin, MBChB, FRCP, MD, and Jean-Michel Molina, MD, PhD, discuss highlights from CCO’s independent conference coverage of CROI 2025, including: Advances in HIV treatment based on results from CARES Potential HIV therapies in the pipeline, such as doravirine/islatravir Effects of broadly neutralizing antibodies on HIV treatment and cure  Key clinical data on HIV and STI preve...